MedPath
HSA Approval

STARFLU-75 CAPSULES 75 MG

SIN15685P

STARFLU-75 CAPSULES 75 MG

STARFLU-75 CAPSULES 75 MG

May 14, 2019

STRIDES PHARMA GLOBAL PTE. LIMITED

STRIDES PHARMA GLOBAL PTE. LIMITED

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantSTRIDES PHARMA GLOBAL PTE. LIMITED
Licence HolderSTRIDES PHARMA GLOBAL PTE. LIMITED

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

CAPSULE

ORAL

Medical Information

J05AH02

oseltamivir

Manufacturer Information

STRIDES PHARMA GLOBAL PTE. LIMITED

Strides Pharma Science Limited

Active Ingredients

Oseltamivir phosphate 98.5mg equivalent to Oseltamivir

75 mg

Oseltamivir

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

STARFLU-75 CAPSULES 75 MG - HSA Approval | MedPath